AWARD. Jonas Hugosson, Professor of Urology, is one of four recipients of the 2016 Nordic Medical Prize. This year’s prize is awarded for research on breast cancer and prostate cancer. Jonas Hugosson will receive the award for his fundamental and internationally publicized prostate cancer screening studies. According to the statement for the award, Jonas Hugosson’s research has been significant for understanding the course of prostate cancer and has paved the way…
Anna Rohlin wrote last year’s best dissertation
PRIZES. Tuesday May 17, Sahlgrenska Academy recognized seven dissertations that were defended at the faculty last year. Anna Rohlin, who received her PhD in clinical genetics, wrote the dissertation crowned the best dissertation of the year 2015. “There are many dissertations from the Sahlgrenska Academy every year, and it feels fantastic to be recognized like this,” said Anna Rohlin. Anna did her dissertation work in Margareta Nordling’s research group in…
The Assar Gabrielsson Award goes to Anna Staffas and Rebecka Arnsrud Godtman
AWARD. For the first time, the Assar Gabrielsson Foundation is dividing its award between two medical researchers. The winners, Anna Staffas and Rebecka Arnsrud Godtman, have carried out acclaimed cancer research within leukemia and prostate cancer screening, respectively. The award amount is SEK 100,000 per person. The Assar Gabrielsson Foundation aims to draw attention to both experimental and patient-based research. This is why, from this year on, two prizes will be…
Distribution of the Assar Gabrielsson award – presentations of the two laureates in cancer research
Assar Gabrielsson Award is given for outstanding dissertation in cancer research, defended at the University of Gothenburg in the last three years. From 2016 two awards in basic scientific medicine and clinical research respectively will be distributed. This year’s award winners are Anna Staffas in basic scientific medicine, and Rebecka Arnsrud Godtman in clinical research. The laureates will each provide a presentation for 20 minutes followed by questions. The presentations…
Clinical development of modern cancer drugs get a boost from a forgotten drug candidate
MEDICAL ARCHEOLOGY. An old drug candidate, from the 1980s, can help new clinical trials find the right patient category for new cancer drugs. That was the conclusion of a researcher couple at Sahlgrenska Academy that dug through the medical literature and discovered a forgotten drug molecule. Work with a new molecule, called RVX2135, awakened interest in the discarded drug candidate. Researcher couple, Jonas and Lisa Nilsson, had shown that RVX2135…